Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

mTOR inhibition: the learning curve in kidney transplantation

(2010) Matthew R. Weir et al.   TRANSPLANT INTERNATIONAL

Sirolimus in Kidney Transplantation Indications and Practical Guidelines: De novo Sirolimus-Based Therapy Without Calcineurin Inhibitors

(2010) Stuart M. Flechner   TRANSPLANTATION

Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

(2010) Robert S. Gaston et al.   TRANSPLANTATION

Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study inDe NovoKidney Allograft Recipients

(2009) S. Busque et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm

(2009) R. S. Gaston   Clinical Journal of the American Society of Nephrology

Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation

(2009) Gerhard Opelz et al.   TRANSPLANTATION